# Systematic Early Use of Neuromuscular Blocking Agents in ARDS Patients

> **NCT00299650** · PHASE4 · COMPLETED · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 340 (estimated)

## Conditions studied

- ARDS

## Interventions

- **DRUG:** cisatracurium
- **DRUG:** Placebo
- **DRUG:** Cisatracurium besilate

## Key facts

- **NCT ID:** NCT00299650
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 340 (ESTIMATED)
- **Last updated:** 2008-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00299650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00299650, "Systematic Early Use of Neuromuscular Blocking Agents in ARDS Patients". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00299650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*